Targeting hypoxia-inducible factors for breast cancer therapy: A narrative review

Hypoxia-inducible factors (HIFs), central regulators for cells to adapt to low cellular oxygen levels, are often overexpressed and activated in breast cancer. HIFs modulate the primary transcriptional response of downstream pathways and target genes in response to hypoxia, including glycolysis, angi...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Shuang, Jiang, Yu, Anfu Zheng, Zhao, Yueshui, Wu, Xu, Li, Mingxing, Du, Fukuan, Chen, Yu, Deng, Shuai, Chen, Meijuan, Li, Wanping, Li, Xiaobing, Gu, Li, Sun, Yuhong, Xiao, Zhangang, Shen, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751339/
https://www.ncbi.nlm.nih.gov/pubmed/36532768
http://dx.doi.org/10.3389/fphar.2022.1064661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751339/
https://www.ncbi.nlm.nih.gov/pubmed/36532768
http://dx.doi.org/10.3389/fphar.2022.1064661

Ejemplares similares